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7RESEARCH ARTICLE Open AccessElectrocardiographic features of disease
progression in arrhythmogenic right
ventricular cardiomyopathy/dysplasia
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Thomas Wolber1,4, Laurent M Haegeli1, Jan Steffel1, Nazmi Krasniqi1, Thomas F Lüscher1,4, Felix C Tanner1,4,
Corinna Brunckhorst1 and Firat Duru1,4*Abstract
Background: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is considered a progressive
cardiomyopathy. However, data on the clinical features of disease progression are limited. The aim of this study was
to assess 12-lead surface electrocardiographic (ECG) changes during long-term follow-up, and to compare these
findings with echocardiographic data in our large cohort of patients with ARVC/D.
Methods: Baseline and follow-up ECGs of 111 patients from three tertiary care centers in Switzerland were
systematically analyzed with digital calipers by two blinded observers, and correlated with findings from
transthoracic echocardiography.
Results: The median follow-up was 4 years (IQR 1.9–9.2 years). ECG progression was significant for epsilon waves
(baseline 14% vs. follow-up 31%, p = 0.01) and QRS duration (111 ms vs. 114 ms, p = 0.04). Six patients with
repolarization abnormalities according to the 2010 Task Force Criteria at baseline did not display these criteria at
follow-up, whereas in all patients with epsilon waves at baseline these depolarization abnormalities also remained
at follow-up. T wave inversions in inferior leads were common (36% of patients at baseline), and were significantly
associated with major repolarization abnormalities (p = 0.02), extensive echocardiographic right ventricular
involvement (p = 0.04), T wave inversions in lateral precordial leads (p = 0.05), and definite ARVC/D (p = 0.05).
Conclusions: Our data supports the concept that ARVC/D is generally progressive, which can be detected by
12-lead surface ECG. Repolarization abnormalities may disappear during the course of the disease. Furthermore,
the presence of T wave inversions in inferior leads is common in ARVC/D.
Keywords: Arrhythmogenic Right Ventricular, Cardiomyopathy, Dysplasia, Electrocardiography, T wave inversionBackground
Arrhythmogenic right ventricular cardiomyopathy/dys-
plasia (ARVC/D) is an inherited heart muscle disorder
characterized by fibro-fatty infiltration of the right ven-
tricle (RV) [1,2]. The disease is a common cause of sudden
cardiac death among young adults and athletes [3-5].
ARVC/D can manifest with multiple facets ranging from
primarily ventricular tachyarrhythmia to biventricular* Correspondence: firat.duru@usz.ch
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unless otherwise stated.heart failure that may eventually lead to heart transplant-
ation or cardiac death [6,7].
The diagnosis of ARVC/D according to the 2010 Task
Force Criteria (TFC) is based on six categories with
major and minor criteria in each. These categories com-
prise: 1. Global or regional dysfunction and structural
alteration of the RV visualized by echocardiography, car-
diac magnetic resonance tomography, or RV angiography 2.
Tissue characterization of the RV free wall by endomyocar-
dial biopsy 3. 12-lead surface electrocardiographic (ECG)
repolarization abnormalities 4. ECG depolarization abnor-
malities 5. Ventricular tachyarrhythmias 6. Family history/
genetic testing. The diagnosis is possible if 2 minor criterial. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and 1 minor or 3 minor criteria are present, and it is defin-
ite if 2 major or 1 major plus 2 minor or 4 minor criteria
are present [6,7].
Recent data suggests that diagnostic features of ARVC/D
such as epsilon waves and T wave inversions (TWI) may
disappear on serial ECG evaluations during follow-up [8],
although ARVC/D is generally considered an irreversible
and progressive cardiomyopathy [9-11]. TWI in inferior
leads have recently been proposed as valuable diagnostic
and prognostic markers in this entity, but have not been in-
corporated in the TFC [12,13]. Whereas TWI in V1- V2 or
in V4, V5, or V6 are a minor criterion for ARVC/D, epsilon
waves constitute a major criterion owing to the fact that ep-
silon waves are rather specific for ARVC/D. Precordial
TWI are more sensitive, but lack specificity as they are
often present in other diseases such as ischemic or con-
genital heart disease. Moreover, precordial TWI in V1-V3
and inferior lead TWI can be observed in a minority of
healthy probands [14]. Since data on clinical features of dis-
ease progression are limited, and correlations between in-
ferior lead TWI and other diagnostic parameters have not
been well defined in ARVC/D, the aim of this study was to
identify associations between inferior lead TWI, other ECG
variables, and echocardiographic findings, and to assess
ECG changes during long-term follow-up in a large cohort
of patients with ARVC/D [14-16].
Methods
Study population
The study population included 111 patients from three
tertiary-care centers in Switzerland with a definite (n = 80),
borderline (n = 19), and possible (n = 12, all first degree
family members of patients with confirmed ARVC/D) diag-
nosis of ARVC/D according to the 2010 TFC, who had an
ECG recorded between February 1987 and March 2013 [7].
This baseline ECG was the first available ECG. Clinical in-
formation regarding demographics and symptoms were ob-
tained from hospital records at the time of the baseline
ECG. Coronary ischemia was ruled out in the presence of
precordial TWI. If patients with precordial TWI presented
with typical angina, or were >35 years old and presented
with ventricular tachycardia or arrhythmogenic syncope,
coronary angiography was performed to rule out signifi-
cant coronary artery disease. In all other patients non-
invasive tests such as cardiac MRI, myocardial perfusion
scintigraphy, stress TTE or treadmill stress testing were
performed to rule out coronary ischemia. This study was
approved by the Ethics Committee of the Canton of Zurich
and the Ethics Committee of the Canton of Bern,
Switzerland, and has been performed in accordance with
the ethical standards laid down in the 1964 Declaration of
Helsinki and its later amendments. Patients gave written in-
formed consent for prospective inclusion in this study.Definitions of 12-lead surface ECG and transthoracic
echocardiography parameters
ECG and transthoracic echocardiography (TTE) defini-
tions and criteria used in this study are presented in
Table 1.
ECG analysis
ECGs were recorded at rest (25 mm/s, 10 mm/mV amp-
litude) with standard lead positions, digitized with a
high-resolution scanner, and analyzed with a digital caliper
(Iconico; screen caliper version 4.0; www.iconico.com)
[15]. To increase the accuracy of measurements, all ECGs
were enlarged four times. ECG intervals were measured in
two consecutive sinus beats in each lead; the mean value
of the two beats was used. If the difference between the
two beats was >10 ms, then the mean of three beats was
taken. Each ECG was independently analyzed by two
blinded experienced readers. Differences in the inter-
pretation of the ECG parameters were adjudicated by a
third cardiologist, and a final conclusion was made by
consensus. ECG variables were measured as previously
described [13].
Transthoracic Echocardiography
Conventional M-mode, 2-D, and color Doppler echocar-
diography was performed in 111 patients at the time of
the baseline ECG by experienced cardiologists according
to guidelines [16,17]. Left ventricular (LV) involvement
was diagnosed when regional wall motion abnormalities
or a reduced ejection fraction (EF <50% by Simpson’s bi-
plane method) were present, and other causes were ex-
cluded [18]. Some ECG data from 90 patients and TTE
data from 70 patients used in this study has been previ-
ously reported by our group [11,13]. While we focused
on predictors of adverse outcome in these previous stud-
ies, the current study investigates ECG changes during
long-term follow-up, and their associations with TTE
findings. Thus, data on follow-up ECGs have not been
previously reported by our group.
Statistical analysis
Continuous variables are presented as mean ± SD or me-
dian (with interquartile ranges, IQR), and were com-
pared using a two-sided t-test or Mann–Whitney U-test,
as appropriate. Categorical variables are reported as fre-
quency (percentage) and compared between groups by
Fisher’s exact test or χ2 –test of independence, as appro-
priate. Logistic univariate regression analysis was used to
correlate between TWI in inferior leads as the response,
and number of precordial leads with TWI as the ex-
planatory variable. For comparison of ECG data be-
tween baseline and follow-up, we used the Wilcoxon
signed-rank test for continuous variables, and Mc
Nemar’s test for categorical variables. A two-sided
Table 1 Definitions of electrocardiographic and echocardiographic parameters used in this study
Variables Definitions
Epsilon wave (major depolarization criterion) Distinct waves of small amplitude that occupy the ST segment
in right precordial leads (V1-V3) and are distinct from the QRS complex
Terminal activation duration (minor depolarization criterion) Longest value in V1 through V3 from the nadir of
the S wave to the end of all depolarization
T wave inversion Any T wave negativity
Inferior leads T wave inversion Inverted T waves in 2 out of 3 inferior leads (II, III, and aVF)
Major repolarization criteria Inverted T waves in right precordial leads (V1, V2, and V3) or beyond
in individuals >14 years of age (in the absence of
complete right bundle branch block)
Minor repolarization criteria - Inverted T waves in leads V1 and V2 in individuals >14 years of
age (in the absence of complete right bundle
branch block) or in V4, V5, or V6
- Inverted T waves in leads V1, V2, V3, and V4 in individuals >14 years
of age in the presence of complete right bundle branch block
Complete right bundle branch block QRSd ≥120 ms and:
A1: R’ or r’ in V1 or V2
A2: S duration > R duration in I and V6
A3: S duration >40 ms in I and V6
A4: R peak time >50 ms in V1 or V2
a: A1 + A2
b: A1+ A3
c: A4+ (A2 or A3)
Incomplete right bundle branch block QRS <120 ms and R peak time in V1 or V2 > 50 ms
QRS notching Additional deflections/notches at the beginning of the QRS,
on top of the R-wave, or in the nadir of the S-wave
in the absence of bundle branch block
Left ventricular involvement Echocardiographic documentation of LV wall motion
abnormalities or a reduced ejection fraction
(<50%) in the absence of other causes
Right ventricular regional wall motion abnormalities Echocardiographic documentation of regional right ventricular akinesia/dyskinesia
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analysis was performed using R programming language
(R Development Core Team, 2009) and GraphPad Prism
5 (GraphPad Software Inc., La Jolla, CA, USA).
Results
Baseline characteristics
Patient baseline characteristics are summarized in
Table 2. A baseline ECG was available in 111 patients.
TTE at the time of the baseline ECG was performed in
all 111 patients. Ninety-eight patients were index pa-
tients, and 13 were family members. Sixty-four (58%) pa-
tients had an implantable cardioverter-defibrillator. ECG
did not display abnormal findings in 14 patients (13%).
Epsilon-waves were most frequently observed in V1
(14%). Epsilon-like waves in any lateral precordial lead
(V4, V5, or V6) were present in a minority of patients
(5%), with one patient displaying these potentials in V2
through V6. Complete right bundle branch block (RBBB)was observed in 14 (13%), incomplete RBBB in 3 (3%),
complete left bundle branch block in 2 (2%), left anterior
fascicular block in 7 (6%), and unspecific QRS notching
in 29 (26%) patients. On echocardiography, regional wall
motion abnormalities were most commonly observed in
the RV subtricuspid region (n = 66; 60%).
12-lead ECG changes during follow-up
A follow-up ECG was available in 77 patients. In the
remaining 34 patients, a follow-up ECG was not ob-
tained due to short follow-up periods (n = 14) or loss of
follow-up/heart transplantation/death (n = 20). The me-
dian time between baseline and follow-up ECG was 4
years (IQR 1.9-9.2 , range 0.3–21.8 , mean 5.6 years).
The follow-up ECG was considered normal in 9 patients
(12%). On average, ECG findings were progressive dur-
ing follow-up, although individual disease course showed
some variations. This progression was statistically sig-
nificant for major depolarization criteria, which was
Table 2 Baseline characteristics
Patient characteristic All patients (n = 111)
Male, n (%) 71 (64%)
Age at baseline ECG (years) 43 (30–56)
Systolic blood pressure (mmHg) 120 ± 19
Diastolic blood pressure (mmHg) 76 ± 9
Heart rate (bpm) 65 (57–74)
Body mass index (kg/m2) 24.3 ± 3.2
Medication
Amiodarone, n (%) 17 (15%)
Beta-blocker, n (%) 47 (42%)
Sotalol, n (%) 13 (12%)
12-lead surface ECG
Epsilon waves in V1, V2, or V3 21 (19%)
Minor ECG depolarization criteria (2010 TFC) 25 (23%)
Terminal activation duration (ms) 52 (43–64)
Major ECG repolarization criteria (2010 TFC) 37 (33%)
Minor ECG repolarization criteria (2010 TFC) 21 (19%)
TWI in inferior leads 38 (34%)
TWI in V4, V5, or V6 43 (39%)
Number of leads with TWI 4.5 ± 2.5
Number of precordial leads with TWI 2.6 ± 1.9
QRS duration (ms) 111 (100–116)
Corrected QT duration (ms) 444 (426–480)
Transthoracic echocardiography
Patients with RV regional wall
motion abnormalities
85 (77%)
1 RV region involved 25 (23%)
≥2 RV regions involved 56 (50%)
Patients with LV involvement 15 (14%)
Abbreviations: ARVC/D Arrhythmogenic right ventricular cardiomyopathy/dysplasia,
LV left ventricular, RV right ventricular, TFC 2010 Revised ARVC/D Task Force Criteria,
TWI T wave inversions.
Values are means ± standard deviation, medians with interquartile ranges and
numbers (percentages).
Table 3 ECG variables in 77 patients, in whom a baseline
and follow-up 12-lead surface ECG was available
ECG variable Baseline
ECG
Follow-up
ECG
p-value
Epsilon waves in V1, V2, or V3 11 (14%) 24 (31%) 0.01
Late potentials in inferior leads 6 (8%) 9 (12%) 0.45
Minor ECG depolarization
criterion
21 (27%) 19 (25%) 0.56
Terminal activation
duration (ms)
50 (44–64) 50 (45–60) 0.47
Major ECG repolarization
criterion
29 (38%) 28 (36%) 0.58
Minor ECG repolarization
criterion
14 (18%) 18 (23%) 0.55
T wave inversions
in inferior leads
28 (36%) 31 (40%) 0.65
T wave inversions
in V4, V5, or V6
33 (43%) 40 (52%) 0.25
Number of leads with
T wave inversions
4 (2-6) 5 (2–7) 0.18
Number of precordial leads
with T wave inversions
2 (1–4) 3 (1–5) 0.1
QRS duration (ms) 111 (100–125) 114 (100–128) 0.04
QT duration (ms) 431 (399–435) 420 (400–441) 0.57
Values are means ± standard deviation, medians with interquartile ranges and
numbers (percentages).
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silon waves in V2 at follow-up, and an increase in the
maximum QRS duration (Table 3). More patients had
TWI in the precordial leads at follow-up. Out of 8 pa-
tients without any precordial TWI at baseline, 4 (50%)
later displayed precordial TWI. An illustrative diagram
of electrocardiographic de- and repolarization abnormal-
ities at baseline and their changes during follow-up is
shown in Figure 1. Three patients with minor repolariza-
tion criteria at baseline did not have any repolarization cri-
teria at follow-up. Four patients with major repolarization
criteria at baseline had minor repolarization criteria in the
absence of complete RBBB at follow-up (Figure 2), whereas
two patients with major repolarization criteria displayed
minor repolarization criteria in the presence of completeRBBB at follow-up. Repolarization criteria were com-
pletely absent in three patients, who had major repolariza-
tion criteria at baseline (Figure 3).
From the patients without epsilon waves at baseline,
19% had these abnormalities at follow-up. In all patients
displaying epsilon waves at baseline these potentials also
remained at follow-up. In one patient, follow-up ECG
revealed a dynamic Brugada-like ECG pattern (Figure 4).
Epsilon-like waves in V4, V5 or V6 were present in a
higher proportion of patients at follow-up compared to
baseline (9%). Median terminal activation duration (TAD)
at follow-up was similar compared to baseline. An in-
crease in the number of precordial leads with TWI was
particularly attributed to new TWI in leads V4 and V5 at
follow-up compared to baseline (49% vs. 36% for V4, and
38% vs. 26% for V5, respectively). At follow-up, complete
RBBB was observed in 12 (16%), incomplete RBBB in 2
(3%), complete left bundle branch block in 2 (3%), left an-
terior fascicular block in 5 (6%), and unspecific QRS
notching in 23 (30%) patients. The maximum corrected
QT interval did not significantly differ between baseline
and follow-up.
Transthoracic echocardiographic findings at follow-up
TTE data was available in all 77 patients at the time of
the follow-up ECG. Echocardiographic data also indicated
disease progression, and correlated with the ECG findings.
Figure 1 Illustrative diagram of changes in depolarization and repolarization criteria during follow-up in patients with ARVC/D.
Patients not presented in this figure remained in the same category of depolarization and repolarization criteria at baseline and follow-up.
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follow-up (26% vs. 14% at baseline, p = 0.04). At follow-up,
15 (19%) patients remained with only one RV region
involved, whereas 48 patients (62%) had ≥2 RV regions in-
volved (p = 0.14 compared to baseline).Baseline ECG
Figure 2 Representative 12-lead surface ECG (25 mm/s, 10 mm/mV) f
task force criteria at baseline (left panel), and minor repolarization cr
normalization of T waves in lead V2 (black arrows, right panel). This v
although R/S transition occurs in V3 in both ECGs. Also note the beat-to-beAssociation between ECG and TTE findings
TWI in inferior leads were significantly associated with
major repolarization criteria (p = 0.02), extensive RV in-
volvement (p = 0.04), the presence of TWI in either lat-
eral precordial lead (V4, V5 or V6; p = 0.05), and theFollow-up ECG
* *
* *
rom a patient with ARVC/D displaying major repolarization 2010
iteria (in the absence of complete RBBB) at follow-up due to
ariation may have been caused by slightly different fixation of V2,
at variation of T wave morphology in leads V3 and V4 (asterisks).
Baseline ECG Follow-up ECG
Figure 3 Representative 12-lead surface ECG (25 mm/s, 10 mm/mV) from a patient with ARVC/D and dynamic repolarization abnormalities,
presumably T wave memory. The left panel shows major repolarization abnormalities according to the 2010 task force criteria at baseline, but no
repolarization criteria at follow-up with normalization of T waves in leads V1-V5 (right panel, black arrows). This patient suffered from sustained
ventricular tachycardia from the RV outflow tract, and imaging revealed akinesia of the RVOT corresponding to scar visualized by electroanatomical
voltage mapping.
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presence of echocardiographic LV involvement (p = 0.11)
did not reach statistical significance. Regional wall motion
abnormalities of the subtricuspid region were not signifi-
cantly associated with TWI in inferior leads (p = 0.16).
Univariate logistic regression revealed a highly signifi-
cant incremental association between the absolute
number of precordial leads with TWI and TWI in inferior
leads (odds ratio 1.45, 95% confidence interval 1.16 - 1.83,
p = 0.001).Discussion
This observational study constitutes the largest series
investigating ECG changes during long-term follow-up
in patients with ARVC/D, and has three main findings:
First, our study supports the concept that ARVC/D is
generally progressive in nature, and that surface 12-lead
ECG is able to detect disease progression. Second, pre-
cordial T wave inversions may disappear during the dis-
ease course, whereas epsilon waves persist; and third,
the presence of TWI in inferior leads is common.Previous studies - disease progression
Except for one study [19], four previous studies have
suggested that ECG changes are generally progressive
in patients with ARVC/D. Yet, the extent and speed of
disease progression shows some individual variability
that may be based on genetic and environmental
factors [9-11,20-22].
Previous studies – dynamic ECG changes
Recent data suggests that electrocardiographic diagnostic
features of ARVC/D such as epsilon waves and TWI may
be dynamic and transient [8], which may potentially impede
appropriate diagnosis of ARVC/D at certain time points
during the disease course, particularly at early stages.Our findings
This study focused on patients with less advanced dis-
ease in comparison to previous studies analyzing data
from patients with more advanced forms of ARVC/D,
and underscores that disease progression can be visual-
ized by consecutive ECG tracings, although the disease
Baseline ECG Follow-up ECG
*
*
Figure 4 12-lead surface ECG (25 mm/s, 10 mm/mV) from a patient with ARVC/D and a dynamic Brugada-like ECG pattern (criteria for
Brugada Type I ECG not fulfilled). The right panel shows a coved-type Brugada-like ECG in leads V1 and V2 at follow-up (black arrows), which is not
visible at baseline (left panel). Also note the T wave inversions in the inferior leads (III and aVF) in the absence of repolarization criteria (asterisks).
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the percentage of patients with epsilon waves and aver-
age QRS duration significantly increased over time, and
the increase in the number of precordial leads with TWI
showed a tendency towards significance. With regard to
TWI, the percentage of patients with precordial TWI
beyond V3 and TWI in inferior leads increased, and cor-
related well with more extensive echocardiographic RV
involvement and new onset LV involvement at follow-
up. ARVC/D has been recently recognized as a biventri-
cular disease with early LV involvement [23]. With
respect to this, repolarization abnormalities beyond V1-
V3, but also inferior lead TWI may serve as early ECG
markers of biventricular involvement and widespread
disease. The fact that depolarization abnormalities ap-
pear to better reflect disease progression compared to
TWI is not completely clear. It is possible that repolar-
ization abnormalities are not only caused by structural
myocardial changes, but may also constitute a physio-
logical variant [14], may vary depending on exercise sta-
tus of a given patient [24], be caused by prolonged
bouts of paroxysmal tachyarrhythmia or frequent ven-
tricular premature contractions, i.e. T wave memory
[25], and subtle differences in positioning the precordial
electrodes, i.e. ECG reproducibility [26]. Anatomic pre-
disposition, particularly in women, may affect lead posi-
tioning, and thus alter the presence and distribution of
leads with TWI (Figure 3). Of note, in this study all fourpatients with major repolarization criteria at baseline,
who presented with minor repolarization criteria in the
absence of complete RBBB at follow-up, were women
[8]. We were also able to document a dynamic Brugada-
like ECG pattern in leads V1/V2 in one patient, as pre-
viously reported, although the criteria for Brugada Type
I ECG were not fulfilled in the absence of J-point eleva-
tion ≥2 mm and TWI in V2 [27,28]. Interestingly, this
patient was one out of 13, in whom TWI in inferior leads
were documented in the absence of major and minor re-
polarization criteria (34% of patients with TWI in inferior
leads). In contrast to the study by Quarta et al. [8], dy-
namic ECG changes in our study primarily originated
from changes in repolarization rather than depolarization
abnormalities. Furthermore, as opposed to that previous
study, all three patients with major repolarization criteria
at baseline and absence of any repolarization criteria at
follow-up had advanced forms of ARVC/D, suggesting
that dynamic repolarization abnormalities may not only
affect early forms of the disease.
Based on our data, depolarization abnormalities
seem to be far less prone to reversal, because they
probably better reflect myocardial infiltration by fibro-
fatty tissue. This interpretation is further supported by
our data on QRS duration, which also significantly in-
creased during follow-up. As the proportion of patients
with antiarrhythmic medication were not significantly
different at baseline and follow-up, and TAD did not
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gression in depolarization abnormalities also affecting
early depolarization such as bundle branch block and QRS
notching. As such, the percentage of patients with RBBB
and QRS notching increased during follow-up.
TWI in inferior leads
The presence of TWI in lateral leads in patients with
ARVC/D is well established, and a noninvasive indica-
tor of biventricular involvement and severe RV dilation
[29-32]. However, data about TWI in inferior leads in
ARVC/D is scarce and their role not completely under-
stood. Whereas most studies support the concept that
TWI in inferior leads are a marker of progressive dis-
ease with extensive RV involvement and LV involve-
ment [31,32], other studies suggest that such ECG
changes could also be associated with isolated wall
motion abnormalities of the subtricuspid region.
Steriotis et al. have recently reported a considerable
prevalence of TWI in inferior leads in ARVC/D, par-
ticularly in the presence of severe RV dilation, but did
not report on the prevalence of LV involvement in their
cohort. Our study confirms these previous findings
with more than one third of patients displaying TWI in
inferior leads at baseline – far more than depolarization
abnormalities in these leads. We further add to the
concept that inferior lead TWI in ARVC/D are associ-
ated with extensive disease as reflected by a significant
association with definite disease status, extensive RV
involvement, and TWI in lateral precordial leads, and a
tendency towards significance for LV involvement. On
the contrary, we did not observe a significant associ-
ation between inferior lead TWI and isolated regional
wall motion abnormalities of the subtricuspid region.
TWI in inferior leads could even constitute markers for
widespread biventricular disease, especially in the presence
of major repolarization abnormalities implying that TWI
in inferior leads may have a rather non-benign character.
Based on our findings, we believe that ECGs obtained
once yearly can serve as an informative, cheap and readily
available monitoring tool. In case of progressive ECG find-
ings, further more expensive diagnostic tests such as echo-
cardiography, cardiac MRI or Holter monitoring can be
performed, and follow-up strategies can be refined. In the
absence of ECG changes and a clinical deterioration dur-
ing follow-up, in our routine clinical practice we perform
TTE every 2 years, and cardiac MRI every 2–5 years to
monitor disease progression. Yet, as an isolated diagnostic
test ECG may not drive therapy per se, and ECG findings
have to be incorporated in the whole clinical picture, espe-
cially when arrhythmic episodes are lacking. Accordingly,
as a sole diagnostic method, ECG is not sensitive and spe-
cific enough to establish the diagnosis of ARVC/D. There-
fore, other diagnostic tests including imaging (e.g. cardiacMRI with stress testing), genetic testing, family history
and endomyocardial biopsy are necessary and required by
the TFC. Since TWI in the precordial leads are not very
specific for ARVC/D, e.g. are commonly seen in patients
suffering from coronary artery disease immediately after a
coronary ischemic episode, and can persist for several
weeks thereafter, it is important to exclude coronary
ischemia by diagnostic tests such as coronary angiography
or cardiac MRI.
Limitations
Due to the observational and partially retrospective nature
of this study, echocardiographic data was mainly obtained
from previous reports. The duration of individual follow-
up and lack of a follow-up ECG in some patients is a limi-
tation that may have led to an underestimation of ECG
changes. Variable ECG filtering may have affected the de-
tection of epsilon waves, but not the detection of TWI,
which was the main reversible ECG feature found in our
cohort. Due to the retrospective study design our ECGs
did not include right-sided chest leads (V1R, V2R, V3R,
V4R), which could be included in future prospective stud-
ies investigating the diagnostic and prognostic utility of
ECG in ARVC/D. Baseline and follow-up cardiac MRI
were only available in a minority of patients, and thus as-
sociations between ECG and MRI findings could not be
addressed in this study.
Conclusions
This study supports the concept that ARVC/D is gener-
ally progressive, which can be detected by 12-lead sur-
face ECG. Repolarization abnormalities may disappear
during the course of the disease. Furthermore, the pres-
ence of TWI in inferior leads is common. Our findings
support the use of 12-lead surface ECG to monitor dis-
ease progression in ARVC/D.
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